The Ticagrelor Market Is Estimated To Witness High Growth Owing To Rising Cardiovascular Diseases

Ticagrelor Market

The Ticagrelor Market is estimated to be valued at US$ 1285.83 Mn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market Overview:
Ticagrelor is an oral antiplatelet drug used to reduce the risk of heart attacks and strokes in patients with acute coronary syndromes or a history of heart attacks without an increased risk of bleeding. Ticagrelor works by reversibly blocking the action of platelets, which are blood components involved in clot formation. By decreasing platelet activity, ticagrelor helps prevent unwanted blood clots from forming and allows blood to flow smoothly. Ticagrelor offers advantages such as greater effectiveness, faster onset of action, and oral route of administration.

Market key trends:
The global ticagrelor market is driven by the rising prevalence of cardiovascular diseases. According to the World Health Organization (WHO), cardiovascular disease is the number 1 cause of death globally, taking an estimated 17.9 million lives each year. Unhealthy diet, physical inactivity, tobacco and alcohol use are major contributors to this rise in cardiovascular disease rates. Elderly population is also at high risk of heart disease. Additionally, rising cases of acute coronary syndrome that require antiplatelet therapy to prevent complications are augmenting the market growth. The market is also witnessing increasing adoption of ticagrelor over clopidogrel due to its superiority in reducing ischemic events without affecting bleeding risk. Manufacturers are investing in R&D of new generic versions and fixed dose combination drugs containing ticagrelor which is further fueling the market growth.

Porter’s Analysis

Threat of new entrants: The threat of new entrants is low due to high capital requirements and regulatory barriers. New companies need huge investments for R&D, clinical trials and manufacturing facilities to enter this market.

Bargaining power of buyers: The bargaining power of buyers is moderate as ticagrelor is available through prescription only. However, availability of alternative treatments provides some bargaining power to buyers.

Bargaining power of suppliers: The bargaining power of suppliers is high as raw material suppliers play a major role in manufacturing this drug. Suppliers can influence prices.

Threat of new substitutes: The threat of new substitutes is high with continuous innovation and presence of alternative antiplatelet drugs.

Competitive rivalry: Intense due to large number of manufacturers.

SWOT Analysis

Strengths: High efficacy and safety profile, large patient pool of cardiovascular diseases.

Weaknesses: Stringent regulatory approvals, patent expiration of major brands.

Opportunities: Emerging markets growth, increasing healthcare spending and awareness.

Threats: Price erosion due to competition, side effects associated.

Key Takeaways

The Global Ticagrelor Market Size is expected to witness high growth, exhibiting CAGR of 12% over the forecast period, due to increasing prevalence of coronary artery disease and strokes. As per the World Health Organization, cardiovascular diseases account for over 17 million deaths annually worldwide.

Regionally, North America is expected to dominate the ticagrelor market owing to growing patient population, advanced healthcare infrastructure and higher adoption of new treatment therapies. However, Asia Pacific is likely to witness fastest growth due to rising healthcare expenditure, large patient pool and increasing focus of key players.

Key players operating in the ticagrelor market are C.H. Boehringer Sohn AG & Ko. KG, Pfizer Inc., Eli Lilly and Company, AstraZeneca plc, Natco Pharma Limited, Anhui Haikang Pharmaceutical Co., Ltd., Avra Laboratories Pvt. Ltd., and Sun Pharmaceutical Industries Ltd. Major players are focusing on product innovation and geographical expansion strategies to strengthen their market presence.

For more insights, read - https://www.rapidwebwire.com/new-avenue-for-ticagrelor-market-growth

Comments

Post a Comment

Popular posts from this blog

Training Market Estimated To Witness High Growth Owing To Growing Emphasis on Developing Skillset

Image
  Training Market The Training Market Is Estimated To Be Valued At US$132.2244 Bn In 2023 And Is Expected To Exhibit A CAGR of 8.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The training market covers products and services related to developing and enhancing skills through workshops, online programs and classroom instructions. This includes corporate training focused on technical, soft and safety skills for varied industries. The key end users are corporates, government organizations and educational institutes. Market Dynamics: The training market is expected to witness significant growth owing to growing emphasis on developing skills to cope with rising complexity and changing nature of jobs. With rapid digitalization and emerging technologies, job roles are transforming significantly necessitating continuous upskilling and reskilling of workforce. This is driving increased demand for training p...
Read more

Salmonella Testing Is Estimated To Witness High Growth Owing To Rising Food Safety Concerns

Image
Salmonella testing market The Salmonella testing market is estimated to be valued at US$ 2.91 Bn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Salmonella testing market involves detection and identification of Salmonella bacteria that causes food poisoning. The key products in the market are assays, kits and reagents that are used to test food samples, clinical samples and environmental samples for the presence of Salmonella. Major end-users include food processing companies, pharmaceutical companies, clinical laboratories and research institutions. Market Dynamics: Rising global outbreaks of foodborne illnesses caused by Salmonella infection is a major factor driving growth of the Salmonella testing market. According to WHO, non-typhoidal Salmonella causes over 90 million cases of gastroenteritis each year globally. Growing consumer awareness abo...
Read more

Global Lab-on-a-Chip and Microarrays (Biochip) Market Is Estimated To Witness High Growth Owing To Rising Demand for Personalized Medicine and Technological Advancements

Image
  Lab-on-a-Chip and Microarrays (Biochip) Market The Lab-on-a-Chip and Microarrays (Biochip) Market is estimated to be valued at US$ 15,268.0 Mn in 2023 and is expected to exhibit a CAGR of 13.43% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Lab-on-a-chip and microarrays (biochip) are innovative technologies that have revolutionized the field of diagnostics and drug discovery. These devices are used for sample analysis and detection of diseases at a molecular level. Lab-on-a-chip platforms offer benefits such as minimal sample requirement, high-throughput analysis, and cost-effective solutions. They find applications in various areas such as genomics, proteomics, and clinical diagnostics, among others. These biochips have the potential to provide personalized medicine by enabling rapid and accurate diagnosis, leading to effective treatments and improved patient outcomes. Market Dynamics: The market ...
Read more